Dosing of First Patient in Phase 2 Clinical Trial of Investigational Soluble Glucagon Formulation for Pumps (Xeris Pharmaceuticals)
Diabetes News Service
Dosing of First Patient in Phase 2 Clinical Trial of Investigational Soluble Glucagon Formulation for Pumps (Xeris Pharmaceuticals)
For iPhone and iPad | For Android devices
For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com
Website by Wired up Wales